Yesterday, March 31, 2016, 47 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $318.82 to $178,000,000.00.

Highlighted Stocks Traded by Insiders:

Realty Income (O) - FREE Research Report

Case John, who is CEO & Director at Realty Income, sold 23,000 shares at $62.53 on March 31, 2016. Following this transaction, the CEO & Director owned 180,401 shares meaning that the stake was reduced by 11.31% with the 23,000-share transaction.

The shares most recently traded at $62.00, down $0.53, or 0.85% since the insider transaction. Historical insider transactions for Realty Income go as follows:

  • 4-Week # shares sold: 3,175
  • 12-Week # shares sold: 63,226
  • 24-Week # shares sold: 96,625

The average volume for Realty Income has been 2.4 million shares per day over the past 30 days. Realty Income has a market cap of $15.6 billion and is part of the financial sector and real estate industry. Shares are up 21.07% year-to-date as of the close of trading on Thursday.

Realty Income Corporation is a publicly traded real estate investment trust. It invests in the real estate markets of the United States. The firm makes investments in commercial real estate. Realty Income Corporation was founded in 1969 and is based in Escondido, California. The stock currently has a dividend yield of 3.84%. The company has a P/E ratio of 57.1. Currently, there are 5 analysts who rate Realty Income a buy, 2 analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on O - FREE

TheStreet Quant Ratings

rates Realty Income as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, expanding profit margins, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Realty Income Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Parexel International (PRXL) - FREE Research Report

Love Richard L, who is Director at Parexel International, sold 1,330 shares at $62.50 on March 31, 2016. Following this transaction, the Director owned 84,110 shares meaning that the stake was reduced by 1.56% with the 1,330-share transaction.

The shares most recently traded at $63.22, up $0.72, or 1.14% since the insider transaction. Historical insider transactions for Parexel International go as follows:

  • 4-Week # shares bought: 455
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 455
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 455
  • 24-Week # shares sold: 7,030

The average volume for Parexel International has been 604,400 shares per day over the past 30 days. Parexel International has a market cap of $3.3 billion and is part of the health care sector and health services industry. Shares are down 7.91% year-to-date as of the close of trading on Thursday.

PAREXEL International Corp, a biopharmaceutical services company, provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company has a P/E ratio of 25.2. Currently, there are 7 analysts who rate Parexel International a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRXL - FREE

TheStreet Quant Ratings

rates Parexel International as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, notable return on equity, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Parexel International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Century Bancorp (CNBKA) - FREE Research Report

Evangelista Paul A, who is Executive Vice President at Century Bancorp, bought 5 shares at $65.46 on March 31, 2016. Following this transaction, the Executive Vice President owned 1,859 shares meaning that the stake was boosted by 0.26% with the 5-share transaction.

The shares most recently traded at $39.00, down $26.46, or 67.85% since the insider transaction. Historical insider transactions for Century Bancorp go as follows:

  • 4-Week # shares bought: 156
  • 12-Week # shares bought: 12,118
  • 24-Week # shares bought: 32,249

The average volume for Century Bancorp has been 4,300 shares per day over the past 30 days. Century Bancorp has a market cap of $216.9 million and is part of the financial sector and banking industry. Shares are down 10.42% year-to-date as of the close of trading on Thursday.

Century Bancorp, Inc. operates as a bank holding company for Century Bank and Trust Company that provides banking products and services. It accepts savings accounts, NOW accounts, demand deposits, time deposits, and money market accounts, as well as cash management accounts. The stock currently has a dividend yield of 1.23%. The company has a P/E ratio of 7.8.

Exclusive Offer: Get the latest Stock Analysis on CNBKA - FREE

TheStreet Quant Ratings

rates Century Bancorp as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and weak operating cash flow. Get the full

Century Bancorp Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.